查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1571781

基於 CRISPR 的基因編輯市場規模、佔有率和趨勢分析報告：按產品/服務、應用、最終用途、地區和細分市場進行預測，2024-2030 年

CRISPR-based Gene Editing Market Size, Share & Trends Analysis Report By Product & Service (CRISPR Kits & Reagents), By Application (Biomedical, Agricultural), By End Use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

基於 CRISPR 的基因編輯市場成長與趨勢：

Grand View Research, Inc.的研究報告顯示，到2030年，全球基於CRISPR的基因編輯市場規模預計將達到91.4億美元，預計2024年至2030年複合年成長率為14.73%。

該市場的強勁成長軌跡歸因於遺傳疾病盛行率上升、CRISPR技術的重大進步、支持性法律規範以及生物技術和醫療保健研究投資增加等幾個關鍵因素的推動。這些因素共同創造了創新和發展的動態環境。

CRISPR 技術的進步正在顯著推動市場擴張。研究人員在開發更精確、更有效率的 CRISPR 系統方面取得了重大進展，包括 CRISPR/Cas9、CRISPR/Cas12 和新的鹼基編輯技術。這些創新擴大了潛在的應用範圍，從治療遺傳性疾病到開發各種癌症和感染疾病的標靶治療。具有高特異性和最小脫靶效應的基因編輯能力的增強引起了製藥和生物技術領域的極大興趣，他們希望利用這些突破性技術進行治療開發。

此外，對個人化醫療的日益重視也對 CRISPR 技術的需求產生了重大影響。隨著醫療保健轉向更個人化的治療方法，精確編輯基因的能力將使開發適合患者獨特基因譜的治療方法成為可能。這種醫學模式轉移可能會進一步加速 CRISPR 技術的採用。因為 CRISPR 技術提供了無與倫比的機會來開發有針對性的有效治療方法，從而顯著改善患者的治療效果。

支持性法律規範營造有利於研究和商業化的環境。監管機構越來越認知到 CRISPR 技術的潛力，從而簡化核准流程，促進創新。總體而言，這些因素的結合將為未來幾年市場的持續成長和創新做好準備，為醫療保健和生物技術的革命性進步鋪平道路。

基於 CRISPR 的基因編輯市場報告亮點

  • 包括CRISPR套件和試劑、CRISPR文庫和其他相關工具在內的產品細分市場以2023年最高的收益佔有率73.96%引領市場。
  • 從應用來看，生物醫藥領域預計將在 2023 年以最高的收益佔有率（81.83%）引領市場，並且在預測期內的複合年成長率（CAGR）最快，達到 15.09%。這一成長是由幾個關鍵促進因素推動的，包括遺傳疾病和癌症盛行率的增加，以及 CRISPR 技術的重大進步。
  • 按最終用途分類，製藥和生物技術公司在 2023 年以 46.31% 的最高收益佔有率引領市場。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第 3 章 基於 CRISPR 的基因編輯市場的變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望。
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
  • 基於 CRISPR 的基因編輯市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • COVID-19 影響分析

第4章 基於CRISPR的基因編輯市場：產品與服務的估算與趨勢分析

  • 細分儀表板
  • 全球CRISPR基因編輯市場產品與服務波動分析
  • 全球基於CRISPR的基因編輯市場規模及趨勢分析：依產品與服務分類，2018-2030年
  • 產品
  • 服務

第5章 基於CRISPR的基因編輯市場：應用預估與趨勢分析

  • 細分儀表板
  • 全球CRISPR基因編輯市場應用變異分析
  • 2018年至2030年基於CRISPR的基因編輯全球市場規模及趨勢分析：依應用分類
  • 生物醫學
    • 2018年至2030年生物醫學市場估計與預測
    • 治療開發
    • 疾病診斷
  • 農業用途
    • 2018年至2030年農業應用市場估計與預測
    • 工廠工程
    • 畜牧工程
    • 其他

第6章 基於 CRISPR 的基因編輯市場：最終用途估計與趨勢分析

  • 細分儀表板
  • 全球基於 CRISPR 的基因編輯市場的最終用途變異分析
  • 2018-2030 年全球基於 CRISPR 的基因編輯市場規模和趨勢分析（按最終用途）
  • 製藥和生物技術公司
  • 學術研究所
  • 受託研究機構

第7章 基於CRISPR的基因編輯市場：區域估算與趨勢分析

  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 2018-2030年市場規模、預測趨勢分析：
  • 北美洲
    • 2018年至2030年北美市場估計與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2018年至2030年歐洲市場估計與預測
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 2018-2030 年亞太市場估計與預測
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 2018年至2030年拉丁美洲市場估計與預測
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 2018年至2030年中東和非洲市場估計和預測
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 公司/競爭對手分類
  • 策略規劃
  • 2023 年企業市場分析
  • 基於CRISPR的基因編輯產品和服務的主要採購商名單
  • 公司簡介/名單
    • Revvity, Inc.
    • Danaher Corporation
    • GenScript
    • Merck KGaA
    • Thermo Fisher Scientific, Inc.
    • Tocris Bioscience
    • OriGene Technologies, Inc.
    • Bio-Rad Laboratories
    • Bio-Techne
    • New England Biolabs, Inc.
Product Code: GVR-4-68040-468-8

CRISPR-based Gene Editing Market Growth & Trends:

The global CRISPR-based gene editing market size is anticipated to reach USD 9.14 billion by 2030 and is projected to grow at a CAGR of 14.73% from 2024 to 2030, according to a report by Grand View Research, Inc. This robust growth trajectory in the market is driven by several key factors, including the rising prevalence of genetic disorders, significant advancements in CRISPR technology, supportive regulatory frameworks, and increasing investments in biotechnology and healthcare research. Together, these elements create a dynamic environment for innovation and development.

Advancements in CRISPR technology have notably fueled market expansion. Researchers have made remarkable progress in developing more precise and efficient CRISPR systems, including CRISPR/Cas9, CRISPR/Cas12, and emerging base editing technologies. These innovations have broadened the scope of potential applications, extending from treating genetic disorders to formulating targeted therapies for various cancers and infectious diseases. The enhanced ability to edit genes with high specificity and minimal off-target effects has captured considerable interest from both pharmaceutical and biotechnology sectors, which are increasingly eager to leverage these groundbreaking technologies for therapeutic development.

Moreover, the growing emphasis on personalized medicine is significantly influencing the demand for CRISPR technologies. As the healthcare landscape shifts toward more individualized treatment approaches, the capability to edit genes with precision enables the creation of therapies tailored to the unique genetic profiles of patients. This paradigm shift in medicine is likely to further accelerate the adoption of CRISPR technologies, as they provide unparalleled opportunities to develop targeted and effective treatments that can dramatically improve patient outcomes.

Supportive regulatory frameworks are fostering a conducive environment for research and commercialization. Regulatory bodies are increasingly recognizing the potential of CRISPR technologies, leading to streamlined approval processes that encourage innovation. Overall, the confluence of these factors positions the market for continued growth and innovation in the coming years, paving the way for revolutionary advancements in healthcare and biotechnology.

CRISPR-based Gene Editing Market Report Highlights:

  • The products segment, which includes CRISPR kits and reagents, CRISPR libraries, and other related tools, led the market with the largest revenue share of 73.96% in 2023
  • Based on application, the biomedical segment led the market with the largest revenue share of 81.83% in 2023 and is also projected to witness at the fastest CAGR of 15.09% during the forecast period. This growth is fueled by several key drivers, including the increasing prevalence of genetic disorders and cancers, alongside significant advancements in CRISPR technology
  • Based on end use, the pharmaceutical & biotechnology companies segment led the market with the largest revenue share of 46.31% in 2023

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Product & Service Segment
    • 1.2.2. Application Segment
    • 1.2.3. End-use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. CRISPR-based Gene Editing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of genetic disorders
      • 3.2.1.2. Growing investments in biotechnology and healthcare research
      • 3.2.1.3. Advancements in CRISPR technology and applications
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Ethical concerns surrounding gene editing
      • 3.2.2.2. High costs associated with CRISPR research and development
  • 3.3. CRISPR-based Gene Editing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. CRISPR-based Gene Editing Market: Product & Service Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global CRISPR-based Gene Editing Market Product & Service Movement Analysis
  • 4.3. Global CRISPR-based Gene Editing Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Million)
  • 4.4. Products
    • 4.4.1. Products market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2. CRISPR Kits & Reagents
      • 4.4.2.1. CRISPR kits & reagents market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3. CRISPR Libraries
      • 4.4.3.1. CRISPR libraries market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.4. Others
      • 4.4.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Services
    • 4.5.1. Services market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. CRISPR-based Gene Editing Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global CRISPR-based Gene Editing Market Application Movement Analysis
  • 5.3. Global CRISPR-based Gene Editing Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Biomedical
    • 5.4.1. Biomedical market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.2. Therapeutic Development
      • 5.4.2.1. Therapeutic development market estimates and forecasts, 2018 to 2030 (USD Million)
      • 5.4.2.2. By Indication
        • 5.4.2.2.1. Genetic Disorders
          • 5.4.2.2.1.1. Genetic Disorders market estimates and forecasts, 2018 to 2030 (USD Million)
        • 5.4.2.2.2. Oncology
          • 5.4.2.2.2.1. Oncology market estimates and forecasts, 2018 to 2030 (USD Million)
        • 5.4.2.2.3. Ophthalmology
          • 5.4.2.2.3.1. Ophthalmology market estimates and forecasts, 2018 to 2030 (USD Million)
        • 5.4.2.2.4. Others
          • 5.4.2.2.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
      • 5.4.2.3. By Delivery Method
        • 5.4.2.3.1. Ex Vivo
        • 5.4.2.3.2. Ex vivo market estimates and forecasts, 2018 to 2030 (USD Million
        • 5.4.2.3.3. In Vivo
        • 5.4.2.3.4. In vivo market estimates and forecasts, 2018 to 2030 (USD Million
    • 5.4.3. Disease Diagnostics
      • 5.4.3.1. Disease diagnostics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Agricultural applications
    • 5.5.1. Agricultural applications market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.5.2. Plant Engineering
      • 5.5.2.1. Plant engineering market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.5.3. Farm Animals Engineering
      • 5.5.3.1. Farm animals engineering market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.5.4. Others
      • 5.5.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. CRISPR-based Gene Editing Market: End-use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global CRISPR-based Gene Editing Market End-use Movement Analysis
  • 6.3. Global CRISPR-based Gene Editing Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
  • 6.4. Pharmaceutical & Biotechnology Companies
    • 6.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Academic & Research Institutes
    • 6.5.1. Academic & research institutes market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Contract Research Organizations
    • 6.6.1. Contract research organizations market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. CRISPR-based Gene Editing Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Competitive scenario
      • 7.4.2.3. Target disease prevalence
      • 7.4.2.4. Regulatory framework
      • 7.4.2.5. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Competitive scenario
      • 7.4.3.3. Target disease prevalence
      • 7.4.3.4. Regulatory framework
      • 7.4.3.5. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Competitive scenario
      • 7.4.4.3. Target disease prevalence
      • 7.4.4.4. Regulatory framework
      • 7.4.4.5. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Competitive scenario
      • 7.5.2.3. Target disease prevalence
      • 7.5.2.4. Regulatory framework
      • 7.5.2.5. UK market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Competitive scenario
      • 7.5.3.3. Target disease prevalence
      • 7.5.3.4. Regulatory framework
      • 7.5.3.5. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Competitive scenario
      • 7.5.4.3. Target disease prevalence
      • 7.5.4.4. Regulatory framework
      • 7.5.4.5. France market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Competitive scenario
      • 7.5.5.3. Target disease prevalence
      • 7.5.5.4. Regulatory framework
      • 7.5.5.5. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Competitive scenario
      • 7.5.6.3. Target disease prevalence
      • 7.5.6.4. Regulatory framework
      • 7.5.6.5. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Competitive scenario
      • 7.5.7.3. Target disease prevalence
      • 7.5.7.4. Regulatory framework
      • 7.5.7.5. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Competitive scenario
      • 7.5.8.3. Target disease prevalence
      • 7.5.8.4. Regulatory framework
      • 7.5.8.5. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key country dynamics
      • 7.5.9.2. Competitive scenario
      • 7.5.9.3. Target disease prevalence
      • 7.5.9.4. Regulatory framework
      • 7.5.9.5. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Target disease prevalence
      • 7.6.2.4. Regulatory framework
      • 7.6.2.5. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive scenario
      • 7.6.3.3. Target disease prevalence
      • 7.6.3.4. Regulatory framework
      • 7.6.3.5. China market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Competitive scenario
      • 7.6.4.3. Target disease prevalence
      • 7.6.4.4. Regulatory framework
      • 7.6.4.5. India market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Competitive scenario
      • 7.6.5.3. Target disease prevalence
      • 7.6.5.4. Regulatory framework
      • 7.6.5.5. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Competitive scenario
      • 7.6.6.3. Target disease prevalence
      • 7.6.6.4. Regulatory framework
      • 7.6.6.5. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Competitive scenario
      • 7.6.7.3. Target disease prevalence
      • 7.6.7.4. Regulatory framework
      • 7.6.7.5. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Target disease prevalence
      • 7.7.2.4. Regulatory framework
      • 7.7.2.5. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive scenario
      • 7.7.3.3. Target disease prevalence
      • 7.7.3.4. Regulatory framework
      • 7.7.3.5. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Competitive scenario
      • 7.8.2.3. Target disease prevalence
      • 7.8.2.4. Regulatory framework
      • 7.8.2.5. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Competitive scenario
      • 7.8.3.3. Target disease prevalence
      • 7.8.3.4. Regulatory framework
      • 7.8.3.5. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Competitive scenario
      • 7.8.4.3. Target disease prevalence
      • 7.8.4.4. Regulatory framework
      • 7.8.4.5. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key country dynamics
      • 7.8.5.2. Competitive scenario
      • 7.8.5.3. Target disease prevalence
      • 7.8.5.4. Regulatory framework
      • 7.8.5.5. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2023
  • 8.4. List of Key Buyers for CRISPR-based Gene Editing Products & Services
  • 8.5. Company Profiles/Listing
    • 8.5.1. Revvity, Inc.
      • 8.5.1.1. Company overview
      • 8.5.1.2. Financial performance
      • 8.5.1.3. Product/Service benchmarking
      • 8.5.1.4. Strategic initiatives
    • 8.5.2. Danaher Corporation
      • 8.5.2.1. Company overview
      • 8.5.2.2. Financial performance
      • 8.5.2.3. Product/Service benchmarking
      • 8.5.2.4. Strategic initiatives
    • 8.5.3. GenScript
      • 8.5.3.1. Company overview
      • 8.5.3.2. Financial performance
      • 8.5.3.3. Product/Service benchmarking
      • 8.5.3.4. Strategic initiatives
    • 8.5.4. Merck KGaA
      • 8.5.4.1. Company overview
      • 8.5.4.2. Financial performance
      • 8.5.4.3. Product/Service benchmarking
      • 8.5.4.4. Strategic initiatives
    • 8.5.5. Thermo Fisher Scientific, Inc.
      • 8.5.5.1. Company overview
      • 8.5.5.2. Financial performance
      • 8.5.5.3. Product/Service benchmarking
      • 8.5.5.4. Strategic initiatives
    • 8.5.6. Tocris Bioscience
      • 8.5.6.1. Company overview
      • 8.5.6.2. Financial performance
      • 8.5.6.3. Product/Service benchmarking
      • 8.5.6.4. Strategic initiatives
    • 8.5.7. OriGene Technologies, Inc.
      • 8.5.7.1. Company overview
      • 8.5.7.2. Financial performance
      • 8.5.7.3. Product/Service benchmarking
      • 8.5.7.4. Strategic initiatives
    • 8.5.8. Bio-Rad Laboratories
      • 8.5.8.1. Company overview
      • 8.5.8.2. Financial performance
      • 8.5.8.3. Product/Service benchmarking
      • 8.5.8.4. Strategic initiatives
    • 8.5.9. Bio-Techne
      • 8.5.9.1. Company overview
      • 8.5.9.2. Financial performance
      • 8.5.9.3. Product/Service benchmarking
      • 8.5.9.4. Strategic initiatives
    • 8.5.10. New England Biolabs, Inc.
      • 8.5.10.1. Company overview
      • 8.5.10.2. Financial performance
      • 8.5.10.3. Product/Service benchmarking
      • 8.5.10.4. Strategic initiatives

List of Tables

  • Table 1. List of abbreviation
  • Table 2. Global CRISPR-based gene editing market, by region, 2018 - 2030 (USD Million)
  • Table 3. Global CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 4. Global CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 5. Global CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 6. North America CRISPR-based gene editing market, by country, 2018 - 2030 (USD Million)
  • Table 7. North America CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 8. North America CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 9. North America CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 10. U.S. CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 11. U.S. CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 12. U.S. CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 13. Canada CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 14. Canada CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 15. Canada CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 16. Mexico CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 17. Mexico CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 18. Mexico CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 19. Europe CRISPR-based gene editing market, by country, 2018 - 2030 (USD Million)
  • Table 20. Europe CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 21. Europe CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 22. Europe CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 23. UK CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 24. UK CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 25. UK CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 26. Germany CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 27. Germany CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 28. Germany CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 29. France CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 30. France CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 31. France CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 32. Italy CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 33. Italy CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 34. Italy CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 35. Spain CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 36. Spain CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 37. Spain CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 38. Denmark CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 39. Denmark CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 40. Denmark CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 41. Sweden CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 42. Sweden CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 43. Sweden CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 44. Norway CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 45. Norway CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 46. Norway CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 47. Asia Pacific CRISPR-based gene editing market, by country, 2018 - 2030 (USD Million)
  • Table 48. Asia Pacific CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 49. Asia Pacific CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 50. Asia Pacific CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 51. Japan CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 52. Japan CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 53. Japan CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 54. China CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 55. China CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 56. China CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 57. India CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 58. India CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 59. India CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 60. Australia CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 61. Australia CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 62. Australia CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 63. South Korea CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 64. South Korea CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 65. South Korea CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 66. Thailand CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 67. Thailand CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 68. Thailand CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 69. Latin America CRISPR-based gene editing market, by country, 2018 - 2030 (USD Million)
  • Table 70. Latin America CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 71. Latin America CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 72. Latin America CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 73. Brazil CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 74. Brazil CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 75. Brazil CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 76. Argentina CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 77. Argentina CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 78. Argentina CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 79. MEA CRISPR-based gene editing market, by country, 2018 - 2030 (USD Million)
  • Table 80. MEA CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 81. MEA CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 82. MEA CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 83. South Africa CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 84. South Africa CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 85. South Africa CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 86. Saudi Arabia CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 87. Saudi Arabia CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 88. Saudi Arabia CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 89. UAE CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 90. UAE CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 91. UAE CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
  • Table 92. Kuwait CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
  • Table 93. Kuwait CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
  • Table 94. Kuwait CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 CRISPR-based Gene Editing market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot-1
  • Fig. 14 Segment snapshot-2
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Market trends & outlook
  • Fig. 17 Porter's five force analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 CRISPR-based Gene editing market: Product & service outlook key takeaways
  • Fig. 20 CRISPR-based Gene editing market: Product & service movement analysis
  • Fig. 21 Products market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 CRISPR kits & reagents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 CRISPR libraries market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 CRISPR-based gene editing market: Application outlook key takeaways
  • Fig. 27 CRISPR-based gene editing market: Application movement analysis
  • Fig. 28 Biomedical market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Therapeutic development market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Genetic disorders market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Ophthalmology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Ex vivo market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 In vivo market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Agricultural applications market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Plant engineering market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Farm animals engineering market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 CRISPR-based gene editing market: End use outlook key takeaways
  • Fig. 42 CRISPR-based gene editing market: End use movement analysis
  • Fig. 43 Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Academic & research Institutes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Contract research organizations market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Regional marketplace outlook, 2023 & 2030 (USD Million)
  • Fig. 47 Regional marketplace: Key takeaways
  • Fig. 48 North America CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 US CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Canada CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 Mexico CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Europe CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 UK CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Germany CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 France CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 Spain CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Italy CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 Denmark CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Sweden CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Norway CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Asia Pacific CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 Japan CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 China CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 India CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Australia CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 South Korea CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 Thailand CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Brazil CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 Argentina CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 South Africa CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Key country dynamics
  • Fig. 92 Saudi Arabia CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 Key country dynamics
  • Fig. 94 UAE CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 Kuwait CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 97 Market participant categorization
  • Fig. 98 Company market position analysis, 2023
  • Fig. 99 Strategic framework